Wendy Su

Wendy Su is an accomplished executive in the pharmaceutical industry, currently serving as Vice President and Global Program Head for the Neuroscience Development Unit at Novartis since April 2018. With a strong background in clinical development and medical affairs, Wendy has previously held significant roles at TG Therapeutics, Inc., where responsibilities included oversight of clinical trials in autoimmune diseases, and at Teva Pharmaceuticals, leading multiple medical science liaison teams and playing a key role in product launches and strategic planning in field medical affairs. Wendy's earlier career includes positions in scientific and medical affairs at EURO RSCG LIFE Chelsea and Memorial Sloan Kettering Cancer Center, complemented by a BA in Biochemistry from Colgate University and a PhD in Pharmacology from Cornell University.